BILL GATES CLEARLY SAYS:
“The world today has 6.8 billion people. That’s heading up to about nine billion. Now if we do a really great job on new vaccines, health care, reproductive health services, we could lower that by perhaps 10 or 15 percent.”
——————————————————————————–
It is well known that the agenda 21 plan was created to depopulate the planet and at the same time profit the big pharma corporations, that are owned by the gloval elite AKA illuminati/bildenberg group
The plan is simple create new diseases spred them to the world create fear ,depopulate…
in other cases they just create the virus spred it,the virus attacks the inmune sistem ,you go to your doctor,your doctor gives you meds,you feel better(not all cases plus you get secondary effects)the meds create long time dependency and to your body and your inmune sistem is down again,then you get more viruses,then you go to your doctor,then…and it goes on and on as profitable bussines
All pandenics where created to depopulate and/or to profit
Also this gloval elite creates wars to depopulate and to profit just think about it,we live in a pyramidal sistem…most of the population lives in the bottom,but who is in the very top? the elite the same group families as always
9/11 false flag inside job from al-C.I.A-eda so the US goverment could have an exuse to depopulate steal and profit from petrolium…also to expand military bases for the next NEW WORLD ORDER and eliminate NWO oposite parties..
They the elite know that this ponzi scheme is colapasing ,they knew that this day was coming,they are going to use the economic colapse to create a new world facsist dictatorial order.
It was all planned…
PLEASE ITS TIME TO WAKE UP STOP BEEING A SHEPPLE ,STOP BEEING A WORKER IN THIS PONZI SCHEME
THE TIME TO CHOOSE WHAT KIND OF FUTURE FOR HUMANITY AND THE PLANET IS NOW!
Assists the searcher in creating a plan to find quality information faster and save time in Searcher In Charge Health Information #1. In the series of Searcher in Charge: Health Information videos, the individual learns how to find and analyze health information needed in their daily life and for consultation with their health care provider. Search techniques, quality health information sources and ways to analyze information and websites, are provided throughout the series of videos so individuals learn to find and review quality health information.
Top insurer tells 1,000 GPs not to give swine flu vaccine
An insurance company has warned 1,000 GPs not to administer the swine flu vaccine.
The HSE plans to enlist family doctors to give the swine flu vaccine to patients with pre-existing medical conditions.
But an insurance company which covers around 1,000 of the 2,200 to 2,500 GPs in the country advised them not to sign up for the work because of legal indemnity issues.
The HSE has given GPs until today to sign up to give the vaccine to 400,000 of their patients with certain medical conditions from next week.
Medisec Ireland, which covers around 1,000 GPs, told their members yesterday not to sign up until all indemnity issues were resolved.
GP sources said last night this may lead some doctors who have signed up to withdraw their participation in the programme.
In a letter to the doctors Medisec said it was unclear where a GP would legally stand if they exercised their discretion not to give the vaccine to their patients.
There are also unresolved legal issues around the doctors identifying and offering the vaccine to at-risk patients.
The company said the Irish Medical Organisation had been trying to negotiate an acceptable resolution to the serious medico/legal issues with the HSE, but had not been successful.
Other concerns relate to the cost of legal representation for doctors who may find themselves before their disciplinary body the Medical Council if they fail to give the vaccine to a patient.
They could also have to go before the same body for exercising their clinical judgment not to administer the vaccine to a patient of another doctor who had been referred to them.
Concern
The letter to GPs said that while the administration of the vaccine would be deemed normal work and covered by a doctor’s policy, the outstanding issues of concern
might not fall into this category due to the amount of work involved and could lead to “adverse indemnity consequences”.
It added: “Accordingly, in the circumstances, we do not recommend our members to sign up for the programme until all issues have been resolved.”
The other company indemnifying doctors, the Medical Protection Society, is believed to have indicated GPs could go ahead with the vaccinations.
The HSE may have to extend today’s deadline for more clarification. It plans to publicise the rollout of the vaccine to at-risk patients tomorrow.
- Eilish O’Regan, Health Correspondent
Irish Independent
Top insurer tells 1,000 GPs not to give swine flu vaccine
An insurance company has warned 1,000 GPs not to administer the swine flu vaccine.
The HSE plans to enlist family doctors to give the swine flu vaccine to patients with pre-existing medical conditions.
But an insurance company which covers around 1,000 of the 2,200 to 2,500 GPs in the country advised them not to sign up for the work because of legal indemnity issues.
The HSE has given GPs until today to sign up to give the vaccine to 400,000 of their patients with certain medical conditions from next week.
Medisec Ireland, which covers around 1,000 GPs, told their members yesterday not to sign up until all indemnity issues were resolved.
GP sources said last night this may lead some doctors who have signed up to withdraw their participation in the programme.
In a letter to the doctors Medisec said it was unclear where a GP would legally stand if they exercised their discretion not to give the vaccine to their patients.
There are also unresolved legal issues around the doctors identifying and offering the vaccine to at-risk patients.
The company said the Irish Medical Organisation had been trying to negotiate an acceptable resolution to the serious medico/legal issues with the HSE, but had not been successful.
Other concerns relate to the cost of legal representation for doctors who may find themselves before their disciplinary body the Medical Council if they fail to give the vaccine to a patient.
They could also have to go before the same body for exercising their clinical judgment not to administer the vaccine to a patient of another doctor who had been referred to them.
Concern
The letter to GPs said that while the administration of the vaccine would be deemed normal work and covered by a doctor’s policy, the outstanding issues of concern
might not fall into this category due to the amount of work involved and could lead to “adverse indemnity consequences”.
It added: “Accordingly, in the circumstances, we do not recommend our members to sign up for the programme until all issues have been resolved.”
The other company indemnifying doctors, the Medical Protection Society, is believed to have indicated GPs could go ahead with the vaccinations.
The HSE may have to extend today’s deadline for more clarification. It plans to publicise the rollout of the vaccine to at-risk patients tomorrow.
- Eilish O’Regan, Health Correspondent
Irish Independent
An insurance company has warned 1,000 GPs not to administer the swine flu vaccine.
The HSE plans to enlist family doctors to give the swine flu vaccine to patients with pre-existing medical conditions.But an insurance company which covers around 1,000 of the 2,200 to 2,500 GPs in the country advised them not to sign up for the work because of legal indemnity issues.
The HSE has given GPs until today to sign up to give the vaccine to 400,000 of their patients with certain medical conditions from next week.
Medisec Ireland, which covers around 1,000 GPs, told their members yesterday not to sign up until all indemnity issues were resolved.
GP sources said last night this may lead some doctors who have signed up to withdraw their participation in the programme.
In a letter to the doctors Medisec said it was unclear where a GP would legally stand if they exercised their discretion not to give the vaccine to their patients.
There are also unresolved legal issues around the doctors identifying and offering the vaccine to at-risk patients.
The company said the Irish Medical Organisation had been trying to negotiate an acceptable resolution to the serious medico/legal issues with the HSE, but had not been successful.
Other concerns relate to the cost of legal representation for doctors who may find themselves before their disciplinary body the Medical Council if they fail to give the vaccine to a patient.
They could also have to go before the same body for exercising their clinical judgment not to administer the vaccine to a patient of another doctor who had been referred to them.
Concern
The letter to GPs said that while the administration of the vaccine would be deemed normal work and covered by a doctor’s policy, the outstanding issues of concern might not fall into this category due to the amount of work involved and could lead to “adverse indemnity consequences”.
It added: “Accordingly, in the circumstances, we do not recommend our members to sign up for the programme until all issues have been resolved.”
The other company indemnifying doctors, the Medical Protection Society, is believed to have indicated GPs could go ahead with the vaccinations.
The HSE may have to extend today’s deadline for more clarification. It plans to publicise the rollout of the vaccine to at-risk patients tomorrow.
Dr Holohan said 1,600 GPs have signed up to give the vaccine to their at-risk patients and another 300 out of over 2,000 doctors have sought clarification on indemnity issues.
The at-risk groups include: women who are over 14 weeks pregnant; women who have given birth in the previous six weeks; those with long-term lung disease like asthma and cystic fibrosis, heart disease and kidney disease among others.
THE Federal Government’s plan to immunise the population against swine flu is in chaos because insurers may not cover doctors who administer the jab.
Inadequate testing and the possibility of spreading other infections means there is too high a risk patients will sue, the insurers say.
Despite weeks of crisis talks, the Government has refused to underwrite doctors’ liability for the vaccinations and medical groups say the program – due to start as early as mid-September – cannot proceed unless doctors are insured.
The president of the Australian Medical Association, Andrew Pesce, said: ”The indemnity issue needs to be sorted out or else the vaccination program won’t go ahead In the environment we’re in, someone has to be held accountable for rare vaccine reactions that may occur
”If the Government decides there is a priority need to roll out the vaccine, then it has a duty to indemnify the doctors who provide it.”
A spokesman for the Royal Australian College of General Practitioners, Ronald McCoy, said the wrangling could undermine community confidence in the vaccine’s safety. ”It’s the public’s health that’s at risk here,” he said.
The Health Minister, Nicola Roxon, announced in May an order with vaccine supplier CSL for 21 million doses – enough to protect at least half the population from the flu strain. Analysts’ estimates suggest that contract may be worth up to $120 million.
But the insurers believe the distribution of the vaccine in multiple-dose vials exposes people to unnecessary risk of blood-borne infection from other recipients. As well, they believe the possibility of rare side-effects has been inadequately explored. These issues, they say, will make it hard for doctors to advise people whether or not to have the injection, exposing them to patient complaints that they were not properly informed.
The chief executive of the Medical Indemnity Industry Association of Australia, Ellen Edmonds-Wilson, said it was up to individual insurers ”to make an assessment of the risk [from] the drug”, which she noted had not yet been approved by the Therapeutic Goods Administration.
Medical defence organisations MDA National Insurance and Avant Mutual Group said they were still considering whether to indemnify members who gave patients the vaccinations. Avant’s general manager of claims, Lisa Clarke, said the entire industry was ”in ongoing discussions with the [health department] on the proposed roll-out.”
A spokeswoman for the Medical Indemnity Protection Society, Elda Rebechi, said the company would cover doctors, but warned them to ”appropriately advise patients that the vaccine is untested and may have [currently] unknown consequences We do not know the risk [or] benefit of the vaccine versus contracting the disease.”
Other companies told the Herald they would insist on a federally funded doctors’ insurance scheme.
But the head of clinical research at the National Centre for Immunisation Research and Surveillance at the University of Sydney, Robert Booy, said the insurers’ arguments were superficial and ”unnecessarily inflammatory”, and proper training of clinicians would virtually eliminate infection risk.
Other doctors questioned the Government’s commitment to multi-dose vials, saying they were ordered when experts feared a severe epidemic.
NSW emergency departments last week saw 203 patients with flu symptoms – down from 338 a week earlier, and a low number compared to regular flu seasons, NSW Health said yesterday.
CSL’s director of public affairs, Rachel David, said the company’s clinical trials were designed to test how much vaccine would be needed to provoke an immune response, not its fundamental safety – which was the same as seasonal flu vaccine.
A spokeswoman for the Department of Health and Ageing said the Government would take delivery of 2 million vaccine doses by the end of August. ”These can be predeployed and stored in states and territories in preparation for an initial vaccine program”, when further CSL trial data was received, she said.
Ms Roxon has said immunisations could start by mid-September, but the spokeswoman emphasised the start date was not set. The program would focus first on health workers, pregnant women and people with chronic disease. Children would receive the shots later.
The department was ”discussing medical indemnity issues for immunisation providers with relevant stakeholders”.
Although infectious exposures to healthcare workers had long been recognized, with the emergence of HIV/AIDS and the resurgence of tuberculosis in the 1980s, emphasis was refocused on PPE for the protection of healthcare workers in all settings. PPE for healthcare includes the respirators, gowns, gloves, face shields, eye protection, and other equipment that will be used by healthcare workers and others in their day-to-day patient care responsibilities. Medical masks (surgical or procedure masks) are not PPE because they are not designed to be used to protect the wearer from hazardous exposures. Prior to the 1980s, the use of healthcare PPE was largely confined to surgical settings and was primarily intended to protect patients rather than healthcare workers. PPE is an important component in the continuum of safety efforts. Occupational safety and health measures have traditionally followed a hierarchy of controls. Engineering controls such as air exchanges or negative-pressure rooms that can isolate the hazard or reduce exposure, are considered the first line of defense against hazardous exposures because they are ubiquitous measures that affect a large number of workers and patients and do not depend on individual compliance. Administrative controls include the policies, standards, and procedures set within an organization to limit hazardous exposures and improve worker safety, including the provision of appropriate and effective protective equipment. At the individual level, responsibilities incumbent on the healthcare worker include appropriate use of PPE as well as adherence to work safety practices. The selection, by employers, of specific PPE options for a given task must be determined within the context of the multiple layers of controls. PPE selection and use is regulated by OSHA in the United States. For more information on PPE in healthcare, go to the 2008 Institute of Medicine report at http://www.iom.edu/CMS/3740/29908/46095.aspx. This is clipped from the 11 minutes video, Personal Protection Against Infection, from the nonprofit Ontario Safety Association for Community and Healthcare and available for purchase at http://www.osach.ca/products/catalog/Infection.html#vinfe344 . This video covers the basics of infection control for health care support staff, from modes of transmission to hand washing to the use of personal protective equipment.
British researchers face recently stated that a newly-identified gene mutation may be responsible for a new class of drug-resistant superbugs. According to ABC News, researchers say a group of plastic surgery patients who traveled from India or Pakistan back to Great Britain returned carrying bacteria which has an antibiotic-resistant “superbug gene” known as NDM-1. NDM-1 stands for New Delhi metallo-beta-lactamase. AFP quotes researchers as saying that a “new class of superbugs…could spread worldwide.” ”The New York Times” quotes experts calling the gene mutation “worrying” and “ominous.”
According to AFP, researchers first discovered the NDM-1 gene in 2009 in a Swedish patient who was hospitalized in India. Scientists are said to be especially concerned because NDM-1 bacteria are resistant to even the strongest, broad-spectrum antibiotics reserved to treat “multi-drug resistant bugs.” In a article from the journal The Lancet, researchers in Britain noted that NDM-1 “can easily be transferred into common bacteria such as E. Coli.” Once the NDM-1 transfer onto the bacteria, they can “easily spread and diversify.” The Lancet piece notes that researchers have found patients in several countries, including the U.S., Netherlands, Australia and Canada, who were found to have “bacteria susceptible to the NDM-1 superbug gene.” Scientists have said that NDM-1 “was impervious to all antibiotics except two.”
In The Lancet, scientists conclude that “The potential of NDM-1 to be a worldwide public health problem is great, and co-ordinated international surveillance is needed.” However, regarding the severity of the bug, as Dr. Martin J. Blaser of New York University says in his interview with the New York Times, “it’s too early to judge.”
For more info about the NDM-1 Superbug, check out these related Mahalo pages:
NDM-1: http://www.mahalo.com/ndm-1
NDM-1 Symptoms: http://www.mahalo.com/ndm-1-symptoms
NDM-1 Transmission: http://www.mahalo.com/ndm-1-transmission
NDM-1 Testing: http://www.mahalo.com/ndm-1-testing
NDM-1 Prevention: http://www.mahalo.com/ndm-1-prevention
NDM-1 Treatments: http://www.mahalo.com/ndm-1-treatments
NDM-1 Health Insurance: http://www.mahalo.com/ndm-1-health-insurance
NDM-1 India: http://www.mahalo.com/ndm-1-india
NDM-1 Travel Advisory: http://www.mahalo.com/ndm-1-travel-advisory
Free NDM-1 Testing: http://www.mahalo.com/free-ndm-1-testing
Superbug: http://www.mahalo.com/superbug
E Coli: http://www.mahalo.com/e-coli
Escherichia Coli: http://www.mahalo.com/escherichia-coli
Gram-negative: http://www.mahalo.com/gram-negative
Klebsiella Pneumoniae: http://www.mahalo.com/klebsiella-pneumoniae
Timothy Walsh: http://www.mahalo.com/timothy-walsh
Check out these other great Mahalo playlists:
How To Pair Wine: http://www.youtube.com/view_play_list?p=64F4800FBC174634
How To Get a Job: http://www.youtube.com/view_play_list?p=0717724A987EF8BF
How To Become a Pharmacist: http://www.youtube.com/view_play_list?p=E42E43E1775B1AE8
How To Become a Photographer: http://www.youtube.com/view_play_list?p=2C523C705B5D715D
How To Sell on eBay for Beginners: http://www.youtube.com/view_play_list?p=E61486D225C8A4A5
How To Start a Blog: http://www.youtube.com/view_play_list?p=BC82FA57A6AC6EDD
How To Use Facebook: http://www.youtube.com/view_play_list?p=5F11AB569088B2F9
How To Play FarmVille: http://www.youtube.com/view_play_list?p=783B260723506DEA
How To Get 3 Stars on Angry Birds 1st World: http://www.youtube.com/view_play_list?p=E32581F286AB34C4
How To Speak Japanese: http://www.youtube.com/view_play_list?p=7B20082F3A7DA3E6
Photo by Roger Schultz:
http://www.flickr.com/photos/elaws/
Photo by MJhoy:
http://www.flickr.com/photos/mjhoy/
Photo by Unlisted Sightings:
http://www.flickr.com/people/unlistedsightings/
Photo by USACE:
http://www.flickr.com/photos/europedistrict/
Photo by Kyle Simourd:
http://www.flickr.com/photos/89241789@N00/
Photo by Esparta:
http://www.flickr.com/photos/66208256@N00/
BILL GATES CLEARLY SAYS:
Assists the searcher in creating a plan to find quality information faster and save time in Searcher In Charge Health Information #1. In the series of Searcher in Charge: Health Information videos, the individual learns how to find and analyze health information needed in their daily life and for consultation with their health care provider. Search techniques, quality health information sources and ways to analyze information and websites, are provided throughout the series of videos so individuals learn to find and review quality health information.
Top insurer tells 1,000 GPs not to give swine flu vaccine
Top insurer tells 1,000 GPs not to give swine flu vaccine
Top insurer tells 1,000 GPs not to give swine flu vaccine
HERE IS THE LINK:
1) UPDATED Vaccine Kills Girl Dies after Cervical Cancer Vaccine HPV jab GlaxoSmithKline Pharma Mafia
60 Minutes, Swine Flu Vaccine Warning, 1979 pt 1 
Although infectious exposures to healthcare workers had long been recognized, with the emergence of HIV/AIDS and the resurgence of tuberculosis in the 1980s, emphasis was refocused on PPE for the protection of healthcare workers in all settings. PPE for healthcare includes the respirators, gowns, gloves, face shields, eye protection, and other equipment that will be used by healthcare workers and others in their day-to-day patient care responsibilities. Medical masks (surgical or procedure masks) are not PPE because they are not designed to be used to protect the wearer from hazardous exposures. Prior to the 1980s, the use of healthcare PPE was largely confined to surgical settings and was primarily intended to protect patients rather than healthcare workers. PPE is an important component in the continuum of safety efforts. Occupational safety and health measures have traditionally followed a hierarchy of controls. Engineering controls such as air exchanges or negative-pressure rooms that can isolate the hazard or reduce exposure, are considered the first line of defense against hazardous exposures because they are ubiquitous measures that affect a large number of workers and patients and do not depend on individual compliance. Administrative controls include the policies, standards, and procedures set within an organization to limit hazardous exposures and improve worker safety, including the provision of appropriate and effective protective equipment. At the individual level, responsibilities incumbent on the healthcare worker include appropriate use of PPE as well as adherence to work safety practices. The selection, by employers, of specific PPE options for a given task must be determined within the context of the multiple layers of controls. PPE selection and use is regulated by OSHA in the United States. For more information on PPE in healthcare, go to the 2008 Institute of Medicine report at http://www.iom.edu/CMS/3740/29908/46095.aspx. This is clipped from the 11 minutes video, Personal Protection Against Infection, from the nonprofit Ontario Safety Association for Community and Healthcare and available for purchase at http://www.osach.ca/products/catalog/Infection.html#vinfe344 . This video covers the basics of infection control for health care support staff, from modes of transmission to hand washing to the use of personal protective equipment.
http://www.mahalo.com/ndm-1-superbug
1) UPDATED Vaccine Kills Girl Dies after Cervical Cancer Vaccine HPV jab GlaxoSmithKline Pharma Mafia